Perioperative Management of the Diabetic Patient Referred to Cardiac Surgery

Braz J Cardiovasc Surg. 2018 Nov-Dec;33(6):618-625. doi: 10.21470/1678-9741-2018-0147.

Abstract

Currently there is a progressive increase in the prevalence of diabetes in a referred for cardiovascular surgery. Benefits of glycemic management (< 180 mg/dL) in diabetic patients compared to patients without diabetes in perioperative cardiac surgery. The purpose of this study is to present recommendations based on international evidence and adapted to our clinical practice for the perioperative management of hyperglycemia in adult patients with and without diabetes undergoing cardiovascular surgery. This update is based on the latest current literature derived from articles and guidelines regarding perioperative management of diabetic patients to cardiovascular surgery.

Publication types

  • Review

MeSH terms

  • Cardiac Surgical Procedures*
  • Clinical Protocols
  • Diabetes Mellitus / drug therapy*
  • Evidence-Based Medicine
  • Humans
  • Hyperglycemia / drug therapy*
  • Hypoglycemic Agents / administration & dosage*
  • Perioperative Care*
  • Postoperative Complications / prevention & control*

Substances

  • Hypoglycemic Agents